Dark

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Sep 2, 2026 3:59:30 PM EDT

2.03USD+0.995%(+0.02)49,881

1.65Bid 2.63Ask 0.98Spread

Pre-market

Sep 3, 2026 9:26:30 AM EDT

2.17USD+7.960%(+0.16)1,680

After-hours

Sep 1, 2026 4:20:30 PM EDT

2.01USD-2.345%(-0.05)0

OverviewHistoricalExchangesShortsMore

open chart

Market Cap

2.34M

Industry

Biotechnology

Last Split

May 15, 20251for28reverse

RNAZ Stats

Avg. Vol. 10 Day

135,316

Avg. Vol. 30 Day

62,990

Employees

Market Cap

2,339,243

Shares Out.

1,058,481

On/Off Exchange

44%/56%

6 Month Beta

0.94

1 Year Beta

0.79

2 Year Beta

0.09

3 Year Beta

0.26

52 Week Low

1.83

52 Week High

20.99

SMA50

5.20

SMA200

7.51

1 Week

-3.07%

1 Month

-47.63%

3 Month

-56.15%

6 Month

-78.44%

1 Year

-78.91%

2 Year

-98.97%

5 Year

-100.00%

Profile

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

RNAZ Stock Summary

TransCode Therapeutics, Inc. Common Stock (NASDAQ:RNAZ) stock price today is $2.03, and today's volume is 49,881. RNAZ is up 0.995% today. The 30 day average volume is 62,990. RNAZ market cap is 2.34M with 1,058,481 shares outstanding.

.dark-mode .ypx6RJ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ypx6RJ{ color: #333333; background-color: white; border: 2px solid #333333; }RNAZTransCode Therapeutics, Inc. Common Stockstock NASDAQ

RNAZ Stock Summary

RNAZ
TransCode Therapeutics, Inc. Common Stock
stock NASDAQ